Filing Details

Accession Number:
0001144204-18-053712
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-12 21:49:38
Reporting Period:
2018-10-12
Accepted Time:
2018-10-12 21:49:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1540159 Stellar Biotechnologies Inc. SBOT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1620188 R. Frank Oakes C/O Stellar Biotechnologies, Inc.
332 East Scott Street
Port Hueneme CA 93041
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Disposition 2018-10-12 3,000 $1.31 51,924 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.